Comparative Pharmacology
Head-to-head clinical analysis: DIETHYLSTILBESTROL versus FEMRING.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIETHYLSTILBESTROL versus FEMRING.
DIETHYLSTILBESTROL vs FEMRING
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Synthetic nonsteroidal estrogen that binds to estrogen receptors (ERα/ERβ), activating estrogen-responsive gene transcription, leading to proliferation of estrogen-sensitive tissues.
Femring (estradiol acetate) is a vaginal ring that releases estradiol, which binds to estrogen receptors (ERα and ERβ) in target tissues, regulating gene transcription and exerting estrogenic effects on the vaginal epithelium, urogenital tract, and other estrogen-sensitive tissues.
0.5-2 mg orally once daily for palliative treatment of advanced prostate cancer; 5-15 mg orally once daily for prevention of postpartum breast engorgement.
Insert one vaginal ring containing 0.05 mg or 0.10 mg estradiol acetate per day; replace every 3 months.
None Documented
None Documented
Clinical Note
moderateDiethylstilbestrol + Digoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digoxin."
Clinical Note
moderateDiethylstilbestrol + Digitoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digitoxin."
Clinical Note
moderateDiethylstilbestrol + Deslanoside
"Diethylstilbestrol may decrease the cardiotoxic activities of Deslanoside."
Clinical Note
moderateDiethylstilbestrol + Acetyldigitoxin
Terminal elimination half-life is approximately 24 hours (range 20-30 hours) in adults; prolonged in hepatic impairment.
The terminal elimination half-life of estradiol from the vaginal ring (Femring) is approximately 36 hours. This extended half-life supports once-monthly dosing and maintains steady-state concentrations.
Primarily renal (90% as glucuronide and sulfate conjugates), with less than 5% excreted unchanged in urine; biliary/fecal elimination accounts for about 10%.
Estradiol is primarily excreted in urine (about 90-95%) as conjugated metabolites (glucuronides and sulfates), with approximately 5-10% eliminated in feces via bile. Less than 5% is excreted unchanged.
Category C
Category C
Estrogen
Estrogen
"Diethylstilbestrol may decrease the cardiotoxic activities of Acetyldigitoxin."